Equitec Proprietary Markets’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,171
Closed -$59.5K 125
2020
Q3
$32K Buy
+9,171
New +$43.5K 0.02% 78
2020
Q1
$18K Buy
+2,575
New +$11.1K 0.01% 241
2018
Q4
$95K Buy
+14,510
New +$163K 0.04% 48
2018
Q1
Sell
-42,536
Closed -$608K 83
2017
Q4
$490K Sell
42,536
-23,552
-36% -$351K 0.15% 41
2017
Q3
$1.26M Buy
66,088
+42,753
+183% +$880K 0.3% 42
2017
Q2
$562K Sell
23,335
-12,747
-35% -$280K 0.13% 61
2017
Q1
$715K Sell
36,082
-517
-1% -$11.5K 0.04% 57
2016
Q4
$881K Buy
36,599
+4,036
+12% +$112K 0.04% 57
2016
Q3
$904K Buy
32,563
+1,553
+5% +$41.1K 0.04% 49
2016
Q2
$756K Sell
31,010
-32,442
-51% -$920K 0.03% 59
2016
Q1
$2.13M Buy
63,452
+51,529
+432% +$1.62M 0.16% 30
2015
Q4
$356K Buy
11,923
+8,492
+248% +$286K 0.02% 84
2015
Q3
$108K Buy
+3,431
New +$167K 0.01% 122

Other funds holding PGEN

Equitec Proprietary Markets's PGEN Position: Q4 2020 in Review

Equitec Proprietary Markets sold out of Precigen (PGEN) in Q4 2020, closing a stake of 9,171 shares — an estimated $59.5K sold.

Equitec Proprietary Markets first reported a position in PGEN in Q3 2015 and held it in 13 quarters. The position peaked at $2.13M in Q1 2016. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

  • Equitec Proprietary Markets reported no remaining Precigen position as of Q4 2020 after selling out during the quarter.
  • Equitec Proprietary Markets sold 9,171 Precigen shares in Q4 2020, an estimated $59.5K.
  • Equitec Proprietary Markets first reported a position in Precigen in Q3 2015 and held it in 13 quarters.
  • Equitec Proprietary Markets's Precigen position peaked at $2.13M in Q1 2016.
  • 151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on Equitec Proprietary Markets's 13F filing for Q4 2020, filed 26 Jan 2021.